Acrolein with an α,β-unsaturated Carbonyl Group Inhibits LPS-induced Homodimerization of Toll-like Receptor 4 |
Lee, Jeon-Soo
(Department of Biomedical Laboratory Science, College of Medical Sciences, Soonchunhyang University)
Lee, Joo Young (Department of Life Science, Gwangju Institute of Science and Technology) Lee, Mi Young (Department of Medical Biotechnology, College of Medical Sciences, Soonchunhyang University) Hwang, Daniel H. (USDA, ARS, Western Human Nutrition Research Center, and Department of Nutrition, University of California) Youn, Hyung Sun (Department of Biomedical Laboratory Science, College of Medical Sciences, Soonchunhyang University) |
1 | Kawai, T., and Akira, S. (2005). Pathogen recognition with Tolllike receptors. Curr. Opin. Immunol. 17, 338-344 DOI ScienceOn |
2 | Lambert, C., Li, J., Jonscher, K., Yang, T.C., Reigan, P., Quintana, M., Harvey, J., and Freed, B.M. (2007). Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-{kappa}B1 DNA binding domain. J. Biol. Chem. 282, 19666-19675 DOI ScienceOn |
3 | Meylan, E., Burns, K., Hofmann, K., Blancheteau, V., Martinon, F., Kelliher, M., and Tschopp, J. (2004). RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat. Immunol. 5, 503-507 DOI ScienceOn |
4 | Na, H.K., and Surh, Y.J. (2006). Transcriptional regulation via cysteine thiol modification: a novel molecular strategy for chemoprevention and cytoprotection. Mol. Carcinog. 45, 368-380 DOI ScienceOn |
5 | Lagrue, G., Branellec, A., and Lebargy, F. (1993). Toxicology of tobacco. Rev. Prat. 43, 1203-1207 |
6 | Fitzgerald, K.A., McWhirter, S.M., Faia, K.L., Rowe, D.C., Latz, E., Golenbock, D.T., Coyle, A.J., Liao, S.M., and Maniatis, T. (2003). IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491-496 DOI ScienceOn |
7 | Youn, H.S., Saitoh, S.I., Miyake, K., and Hwang, D.H. (2006c). Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem. Pharmacol. 72, 62-69 |
8 | Lee, J.Y., and Hwang, D.H. (2006). The modulation of inflammatory gene expression by lipids: mediation through Tolllike receptors. Mol. Cells 21, 174-185 |
9 | Miyake, K. (2004). Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. Trends Microbiol. 12, 186-192 DOI ScienceOn |
10 | Kehrer, J.P., and Biswal, S.S. (2000). The molecular effects of acrolein. Toxicol. Sci. 57, 6-15 DOI ScienceOn |
11 | Vogel, S.N., Fitzgerald, K.A., and Fenton, M.J. (2003). TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol. Interv. 3, 466-477 DOI ScienceOn |
12 | Youn, H.S., Lee, J.Y., Saitoh, S.I., Miyake, K., Kang, K.W., Choi, Y.J., and Hwang, D.H. (2006b). Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea. Biochem. Pharmacol. 72, 850-859 DOI ScienceOn |
13 | Medzhitov, R. (2001). Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1, 135-145 DOI ScienceOn |
14 | Ghilarducci, D.P., and Tjeerdema, R.S. (1995). Fate and effects of acrolein. Rev. Environ. Contam. Toxicol. 144, 95-146 |
15 | Saitoh, S., Akashi, S., Yamada, T., Tanimura, N., Kobayashi, M., Konno, K., Matsumoto, F., Fukase, K., Kusumoto, S., Nagai, Y., et al. (2004). Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization. Int. Immunol. 16, 961-969 DOI ScienceOn |
16 | Sato, S., Sugiyama, M., Yamamoto, M., Watanabe, Y., Kawai, T., Takeda, K., and Akira, S. (2003). Toll/IL-1 receptor domaincontaining adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J. Immunol. 171, 4304-4310 DOI |
17 | Li, L., Hamilton, R.F.Jr., and Holian, A. (1999). Effect of acrolein on human alveolar macrophage NF-kappaB activity. Am. J. Physiol. 277, L550-557 |
18 | Youn, H.S., Lee, J.Y., Saitoh, S.I., Miyake, K., and Hwang, D.H. (2006a). Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4. Biochem. Biophys. Res. Commun. 350, 866-871 DOI ScienceOn |
19 | Rhee, S.H., and Hwang, D. (2000). Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase. J. Biol. Chem. 275, 34035-34040 DOI ScienceOn |
20 | Takeda, K., and Akira, S. (2005). Toll-like receptors in innate immunity. Int. Immunol. 17, 1-14 |
21 | Youn, H.S., Lee, J.Y., Fitzgerald, K.A., Young, H.A., Akira, S., and Hwang, D.H. (2005). Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J. Immunol. 175, 3339-3346 DOI |
22 | Horton, N.D., Biswal, S.S., Corrigan, L.L., Bratta, J., and Kehrer, J.P. (1999). Acrolein causes inhibitor kappaBindependent decreases in nuclear factor kappaB activation in human lung adenocarcinoma (A549) cells. J. Biol. Chem. 274, 9200-9206 DOI ScienceOn |
23 | O'Neill, L.A. (2004). TLRs: Professor Mechnikov, sit on your hat. Trends Immunol. 25, 687-693 DOI ScienceOn |
24 | Anderson, M.M., Hazen, S.L., Hsu, F.F., and Heinecke, J.W. (1997). Human neutrophils employ the myeloperoxidasehydrogen peroxide-chloride system to convert hydroxyamino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha- hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation. J. Clin. Invest 99, 424-432 DOI ScienceOn |
25 | Valacchi, G., Pagnin, E., Phung, A., Nardini, M., Schock, B.C., Cross, C.E., and van der Vliet, A. (2005). Inhibition of NFkappaB activation and IL-8 expression in human bronchial epithelial cells by acrolein. Antioxid. Redox Signal. 7, 25-31 DOI ScienceOn |